Oncolys BioPharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023

Oncolys BioPharma Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was JPY 63.04 million compared to JPY 426.15 million a year ago. Net loss was JPY 868.76 million compared to JPY 570.57 million a year ago.